| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G |
| 13 Nov 2026 |
8-K: Other Events
On November 12, 2026, Tandem Diabetes Care, Inc. (the “Company”) received 510(k) clearance from the U.S. Food and Drug Administration for Tandem Mobi, the world’s first and only tubeless automated insulin delivery system with up to 7 day... |
| 09 Nov 2026 | SCHEDULE 13G |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
San Diego, November 5, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2026. |
| 29 Oct 2026 |
Form 4: Twomey Christopher J, Director
Received 1,700 shares by exercise or conversion ($32.3K) · Sold 1,700 shares ($32.6K) |
| 27 Oct 2026 | 144 |
| 19 Oct 2026 |
Form 4: Kyrillos Jean-Claude, EVP & Chief Operating Officer
Received 3,637 shares by exercise or conversion · Gave up 1,926 shares to cover exercise price or tax ($31.8K) |
| 17 Sep 2026 | 144 |
| 18 Aug 2026 |
Form 4: Vosseller Leigh, EVP & CHIEF FINANCIAL OFFICER
Received 4,120 shares by exercise or conversion · Gave up 1,479 shares to cover exercise price or tax ($33.6K) |
| 18 Aug 2026 |
Form 4: Sheridan John F, Director
Received 15,916 shares by exercise or conversion · Gave up 8,099 shares to cover exercise price or tax ($184K) |
| 18 Aug 2026 |
Form 4: Morrison Susan, EVP & Chief Admin. Officer
Received 2,827 shares by exercise or conversion · Gave up 809 shares to cover exercise price or tax ($18.4K) |
| 18 Aug 2026 |
Form 4: Kyrillos Jean-Claude, EVP & Chief Operating Officer
Received 1,010 shares by exercise or conversion · Gave up 535 shares to cover exercise price or tax ($12.2K) |
| 18 Aug 2026 |
Form 4: Gasser Elizabeth Anne, EVP, Chief Strategy Officer
Received 3,014 shares by exercise or conversion · Gave up 1,618 shares to cover exercise price or tax ($36.8K) |
| 18 Aug 2026 |
Form 4: Carpenter Rick, EVP & Chief Technology Officer
Received 2,507 shares by exercise or conversion · Gave up 1,277 shares to cover exercise price or tax ($29K) |
| 18 Aug 2026 |
Form 4: Hansen Shannon Marie, EVP & Chief Legal Officer
Received 3,014 shares by exercise or conversion · Gave up 1,535 shares to cover exercise price or tax ($34.9K) |
| 18 Aug 2026 | 144 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
San Diego, August 6, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2026. |
Loading...